Literature DB >> 28143860

Hepatitis E virus infection in a patient with suspected drug-induced liver injury.

Ashfaque Memon1, Jose Miranda2.   

Abstract

A 58 years old woman, known case of multiple sclerosis, was referred to the acute medical assessment unit for worsening liver function. She was recently started on a new drug (fingolimod) for multiple sclerosis. After excluding common causes of acute hepatitis in the community, a working diagnosis of drug-induced liver injury was made. When liver enzymes kept rising, further investigations were carried out, which revealed acute hepatitis E virus (HEV) infection. This finding was unexpected, as this patient had no risk factor to acquire HEV infection and there was not a single case of HEV diagnosed in our hospital since long time. This case report highlights certain issues like, considering rarest possible diagnosis when meeting such clinical case, concern over the infections which were once thought confined to the developing countries and inclusion of HEV workup in the cases of acute hepatitis when baseline workup is inconclusive. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28143860      PMCID: PMC5293955          DOI: 10.1136/bcr-2016-218387

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Fingolimod for multiple sclerosis.

Authors:  Daniel Pelletier; David A Hafler
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

2.  Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.

Authors:  Timothy J Davern; Naga Chalasani; Robert J Fontana; Paul H Hayashi; Petr Protiva; David E Kleiner; Ronald E Engle; Hanh Nguyen; Suzanne U Emerson; Robert H Purcell; Hans L Tillmann; Jiezhun Gu; Jose Serrano; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2011-08-16       Impact factor: 22.682

3.  Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.

Authors:  Robert J Fontana; Leonard B Seeff; Raúl J Andrade; Einar Björnsson; Christopher P Day; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 4.  Hepatitis E.

Authors:  Nassim Kamar; Richard Bendall; Florence Legrand-Abravanel; Ning-Shao Xia; Samreen Ijaz; Jacques Izopet; Harry R Dalton
Journal:  Lancet       Date:  2012-04-30       Impact factor: 79.321

Review 5.  Hepatitis E: an emerging infection in developed countries.

Authors:  Harry R Dalton; Richard Bendall; Samreen Ijaz; Malcolm Banks
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

6.  Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

Authors:  Jeffrey A Cohen; Frederik Barkhof; Giancarlo Comi; Hans-Peter Hartung; Bhupendra O Khatri; Xavier Montalban; Jean Pelletier; Ruggero Capra; Paolo Gallo; Guillermo Izquierdo; Klaus Tiel-Wilck; Ana de Vera; James Jin; Tracy Stites; Stacy Wu; Shreeram Aradhye; Ludwig Kappos
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

7.  Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

Authors:  Nassim Kamar; Janick Selves; Jean-Michel Mansuy; Leila Ouezzani; Jean-Marie Péron; Joëlle Guitard; Olivier Cointault; Laure Esposito; Florence Abravanel; Marie Danjoux; Dominique Durand; Jean-Pierre Vinel; Jacques Izopet; Lionel Rostaing
Journal:  N Engl J Med       Date:  2008-02-21       Impact factor: 91.245

8.  Drug-induced liver injury: summary of a single topic clinical research conference.

Authors:  Paul B Watkins; Leonard B Seeff
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

9.  Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.

Authors:  Harry R Dalton; William Stableforth; Prem Thurairajah; Simon Hazeldine; Rene Remnarace; Warshow Usama; Liz Farrington; Noor Hamad; Cyril Sieberhagen; Vic Ellis; Jonathan Mitchell; S Hyder Hussaini; Malcolm Banks; Samreen Ijaz; Richard P Bendall
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-08       Impact factor: 2.566

10.  Hepatitis E virus antibodies in blood donors, France.

Authors:  Jean-Michel Mansuy; Richard Bendall; Florence Legrand-Abravanel; Karine Sauné; Marcel Miédouge; Vic Ellis; Henri Rech; François Destruel; Nassim Kamar; Harry R Dalton; Jacques Izopet
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

View more
  3 in total

1.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

Review 2.  Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection.

Authors:  Harini Sooryanarain; Xiang-Jin Meng
Journal:  Virus Res       Date:  2020-04-23       Impact factor: 3.303

Review 3.  The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.

Authors:  Marco Biolato; Assunta Bianco; Matteo Lucchini; Antonio Gasbarrini; Massimiliano Mirabella; Antonio Grieco
Journal:  CNS Drugs       Date:  2021-07-28       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.